Indications
Treatment of major depressive episodes in adults.
Composition
- Active substance
- agomelatine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Valdoxan
- Active substance
- agomelatine
- ATC code
- N06AX22
- Group
- Nervous system
- Therapeutic area
- Depressive Disorder, Major
- Marketing authorisation holder
- Les Laboratoires Servier
- Status
- Authorised
- EU authorisation
- 19 Feb 2009
- EMA product number
- EMEA/H/C/000915